Leo Poon | Academic Influence

Leo Poon's AcademicInfluence.com Rankings

Leo Poon

Biology

#3216

World Rank

#4946

Historical Rank

Virology

#69

World Rank

#72

Historical Rank

Microbiology

#203

World Rank

#239

Historical Rank

biology Degrees

Download Badge

Biology

Leo Poon's Degrees

Bachelors Biology University of California, Berkeley
PhD Microbiology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Leo Poon Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Leo Poon is the Head of the Division of Public Health Laboratory Science of the University of Hong Kong. In July 2020, Professor Malik Peiris stepped down from the position of co-director of the joint research pole between Hong Kong University and the Pasteur Institute , and Professor Leo Poon succeeded to this crucial WHO recognized Centre. He is one of the worlds' leading scientists investigating the emergence of viral diseases transferring from animals to humans, such as new strains of Influenza viruses and coronaviruses. Along with colleagues in his Division, he has made major contributions to the understanding of disease causes, diagnostic testing, and epidemiological control of these pandemic viral diseases.

(See a Problem?)

Leo Poon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (2020) (5195)
Coronavirus as a possible cause of severe acute respiratory syndrome (2003) (2886)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study (2003) (2317)
Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China (2003) (2207)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings (2004) (1591)
Stability of SARS-CoV-2 in different environmental conditions (2020) (1467)
Viral dynamics in mild and severe cases of COVID-19 (2020) (1462)
Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia (2005) (1381)
Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (2020) (1373)
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 (2003) (1349)
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia (2004) (1346)
Viral load of SARS-CoV-2 in clinical samples (2020) (1320)
Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage (2003) (1161)
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia (2020) (1101)
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group (2013) (1101)
Lung pathology of fatal severe acute respiratory syndrome (2003) (1041)
Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? (2002) (946)
The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus (2011) (844)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses (2011) (779)
Pathogenesis and transmission of SARS-CoV-2 in golden Syrian hamsters (2020) (732)
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells (2008) (701)
Highly Conserved Protective Epitopes on Influenza B Viruses (2012) (661)
Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants (2006) (596)
Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells (2005) (533)
Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. (2006) (459)
Dating the emergence of pandemic influenza viruses (2009) (448)
Reemerging H5N1 Influenza Viruses in Hong Kong in 2002 Are Highly Pathogenic to Ducks (2004) (438)
The genesis and source of the H7N9 influenza viruses causing human infections in China (2013) (430)
Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures (2020) (417)
Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis (2005) (410)
H5N1 influenza: a protean pandemic threat. (2004) (408)
Reassortment of Pandemic H1N1/2009 Influenza A Virus in Swine (2010) (384)
Identification of a Novel Coronavirus in Bats (2005) (376)
Infection of dogs with SARS-CoV-2 (2020) (367)
Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. (2009) (356)
Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract (2007) (353)
Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. (2001) (350)
Three Indonesian clusters of H5N1 virus infection in 2005. (2006) (347)
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo (2022) (346)
Prevalence and Genetic Diversity of Coronaviruses in Bats from China (2006) (338)
Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. (2013) (338)
Detection of SARS Coronavirus in Patients with Suspected SARS (2004) (307)
Human Coronavirus NL63 Infection and Other Coronavirus Infections in Children Hospitalized with Acute Respiratory Disease in Hong Kong, China (2005) (299)
Infectivity, Transmission, and Pathology of Human-Isolated H7N9 Influenza Virus in Ferrets and Pigs (2013) (297)
Presence of fetal RNA in maternal plasma. (2000) (295)
MERS Coronaviruses in Dromedary Camels, Egypt (2014) (295)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters (2020) (283)
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 (2020) (279)
Viral Loads in Clinical Specimens and SARS Manifestations (2004) (278)
Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. (2006) (270)
MERS Coronavirus in Dromedary Camel Herd, Saudi Arabia (2014) (269)
The first 2019 novel coronavirus case in Nepal (2020) (265)
Neutralizing antibody titres in SARS-CoV-2 infections (2021) (262)
Charaterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? (2003) (254)
Codon usage bias and the evolution of influenza A viruses. Codon Usage Biases of Influenza Virus (2010) (250)
Continuing Evolution of H9N2 Influenza Viruses in Southeastern China (2004) (249)
Influenza: Emergence and Control (2004) (249)
Long-term evolution and transmission dynamics of swine influenza A virus (2011) (238)
The nsp9 Replicase Protein of SARS-Coronavirus, Structure and Functional Insights (2004) (232)
Novel Astroviruses in Insectivorous Bats (2008) (230)
Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (2020) (218)
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination (2022) (216)
Direct Evidence that the Poly(A) Tail of Influenza A Virus mRNA Is Synthesized by Reiterative Copying of a U Track in the Virion RNA Template (1999) (213)
Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. (2013) (211)
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015 (2017) (206)
Early diagnosis of SARS Coronavirus infection by real time RT-PCR (2003) (205)
Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. (2002) (201)
Evidence for an Ancestral Association of Human Coronavirus 229E with Bats (2015) (197)
Dissemination, divergence and establishment of H7N9 influenza viruses in China (2015) (196)
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease (2020) (195)
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections (2020) (194)
Hemagglutinin–neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets (2011) (194)
Initial viral load and the outcomes of SARS (2004) (193)
A Case for the Ancient Origin of Coronaviruses (2013) (193)
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19 (2020) (190)
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection (2020) (181)
Canine SARS-CoV-2 infection (2020) (174)
Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures (2013) (170)
Evaluation of Reverse Transcription-PCR Assays for Rapid Diagnosis of Severe Acute Respiratory Syndrome Associated with a Novel Coronavirus (2003) (168)
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse (2021) (168)
Mass extinctions, biodiversity and mitochondrial function: are bats ‘special’ as reservoirs for emerging viruses? (2011) (166)
The Severe Acute Respiratory Syndrome (SARS) Coronavirus NTPase/Helicase Belongs to a Distinct Class of 5′ to 3′ Viral Helicases* (2003) (163)
Quantifying influenza virus diversity and transmission in humans (2016) (163)
The aetiology, origins, and diagnosis of severe acute respiratory syndrome (2004) (161)
The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. (2008) (156)
Induction of Proinflammatory Cytokines in Primary Human Macrophages by Influenza A Virus (H5N1) Is Selectively Regulated by IFN Regulatory Factor 3 and p38 MAPK1 (2009) (155)
Amino Acid Substitutions in Polymerase Basic Protein 2 Gene Contribute to the Pathogenicity of the Novel A/H7N9 Influenza Virus in Mammalian Hosts (2014) (145)
MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity (2018) (145)
Detection of Human Influenza A Viruses by Loop-Mediated Isothermal Amplification (2005) (143)
Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea (2015) (142)
Biology of Influenza A Virus (2007) (141)
Rapid Diagnosis of a Coronavirus Associated with Severe Acute Respiratory Syndrome (SARS) (2003) (141)
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin (2018) (141)
Emergence of a novel human coronavirus threatening human health (2020) (141)
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. (2020) (140)
Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection (2005) (139)
Time Course and Cellular Localization of SARS-CoV Nucleoprotein and RNA in Lungs from Fatal Cases of SARS (2006) (138)
Avian Coronavirus in Wild Aquatic Birds (2011) (137)
Detection of SARS Coronavirus in Patients with Severe Acute Respiratory Syndrome by Conventional and Real-Time Quantitative Reverse Transcription-PCR Assays (2004) (136)
Molecular Detection of a Novel Human Influenza (H1N1) of Pandemic Potential by Conventional and Real-Time Quantitative RT-PCR Assays (2009) (136)
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021 (2021) (134)
Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome (2004) (133)
A Surface Coating that Rapidly Inactivates SARS-CoV-2 (2020) (131)
Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal (2020) (130)
Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. (2010) (130)
Generic Detection of Coronaviruses and Differentiation at the Prototype Strain Level by Reverse Transcription-PCR and Nonfluorescent Low-Density Microarray (2007) (128)
Analytical sensitivity of rapid influenza antigen detection tests for swine-origin influenza virus (H1N1). (2009) (126)
Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. (2008) (126)
Detection of a Novel and Highly Divergent Coronavirus from Asian Leopard Cats and Chinese Ferret Badgers in Southern China (2007) (124)
Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. (2014) (120)
Rapid Detection of the Severe Acute Respiratory Syndrome (SARS) Coronavirus by a Loop-Mediated Isothermal Amplification Assay (2004) (113)
Establishment of Influenza A Virus (H6N1) in Minor Poultry Species in Southern China (2007) (110)
Serological Responses in Patients with Severe Acute Respiratory Syndrome Coronavirus Infection and Cross-Reactivity with Human Coronaviruses 229E, OC43, and NL63 (2005) (108)
Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. (2010) (108)
Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study (2014) (106)
Stalking influenza by vaccination with pre-fusion headless HA mini-stem (2016) (105)
Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats. (2008) (105)
The Viruses of Wild Pigeon Droppings (2013) (103)
Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract (2013) (101)
Retinoic acid induces down-regulation of Wnt-3a, apoptosis and diversion of tail bud cells to a neural fate in the mouse embryo (1999) (99)
Detection of diverse astroviruses from bats in China. (2009) (94)
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections (2020) (94)
Inhibition of SARS-associated coronavirus infection and replication by RNA interference. (2003) (91)
Lack of Middle East Respiratory Syndrome Coronavirus Transmission from Infected Camels (2015) (90)
Detection of novel astroviruses in urban brown rats and previously known astroviruses in humans (2010) (87)
Generation and characterization of influenza A viruses with altered polymerase fidelity (2014) (86)
Mini viral RNAs act as innate immune agonists during influenza virus infection (2018) (85)
Avian influenza H5N1 in viverrids: implications for wildlife health and conservation (2006) (85)
Influenza A Virus Expresses High Levels of an Unusual Class of Small Viral Leader RNAs in Infected Cells (2010) (84)
Loop-Mediated Isothermal Amplification for Influenza A (H5N1) Virus (2007) (82)
Polyadenylation of Influenza Virus mRNA Transcribed In Vitro from Model Virion RNA Templates: Requirement for 5′ Conserved Sequences (1998) (80)
Coronaviruses in bent-winged bats (Miniopterus spp.). (2006) (78)
Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study (2022) (78)
Expansion of Genotypic Diversity and Establishment of 2009 H1N1 Pandemic-Origin Internal Genes in Pigs in China (2014) (74)
The RNA Polymerase of Influenza Virus, Bound to the 5′ End of Virion RNA, Acts in cis To Polyadenylate mRNA (1998) (74)
A Hairpin Loop at the 5′ End of Influenza A Virus Virion RNA Is Required for Synthesis of Poly(A)+ mRNA In Vitro (1999) (73)
Characterization of a novel gyrovirus in human stool and chicken meat. (2012) (72)
Potent inhibition of SARS-associated coronavirus (SCoV) infection and replication by type I interferons (IFN-α/β) but not by type II interferon (IFN-γ) (2004) (72)
Full Factorial Analysis of Mammalian and Avian Influenza Polymerase Subunits Suggests a Role of an Efficient Polymerase for Virus Adaptation (2009) (71)
Serial Analysis of the Plasma Concentration of SARS Coronavirus RNA in Pediatric Patients with Severe Acute Respiratory Syndrome (2003) (70)
Human Annexin A6 Interacts with Influenza A Virus Protein M2 and Negatively Modulates Infection (2011) (70)
Asymptomatic MERS-CoV Infection in Humans Possibly Linked to Infected Dromedaries Imported from Oman to United Arab Emirates, May 2015 (2015) (69)
Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein (2004) (68)
The Complete Genome Sequence of Severe Acute Respiratory Syndrome Coronavirus Strain HKU-39849 (HK-39) (2003) (66)
Prenatal detection of fetal Down's syndrome from maternal plasma (2000) (65)
Cupric Oxide Coating That Rapidly Reduces Infection by SARS-CoV-2 via Solids (2021) (64)
Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014–2015 (2017) (64)
Emergence and Dissemination of a Swine H3N2 Reassortant Influenza Virus with 2009 Pandemic H1N1 Genes in Pigs in China (2011) (63)
A Novel Group of Avian Astroviruses in Wild Aquatic Birds (2012) (60)
Stability of SARS-CoV-2 in different environmental conditions – Authors' reply (2020) (60)
Vaccinia Virus-Based Multivalent H5N1 Avian Influenza Vaccines Adjuvanted with IL-15 Confer Sterile Cross-Clade Protection in Mice1 (2009) (60)
A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase. (2009) (60)
Evaluation of Real-Time Reverse Transcriptase PCR and Real-Time Loop-Mediated Amplification Assays for Severe Acute Respiratory Syndrome Coronavirus Detection (2005) (59)
Viral reassortment as an information exchange between viral segments (2012) (58)
The spread of the H5N1 bird flu epidemic in Asia in 2004. (2005) (58)
Entry of Influenza A Virus with a α2,6-Linked Sialic Acid Binding Preference Requires Host Fibronectin (2012) (56)
Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. (2015) (54)
A one step quantitative RT-PCR for detection of SARS coronavirus with an internal control for PCR inhibitors (2004) (54)
Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). (2004) (54)
H 5 N 1 influenza : A protean pandemic threat (2005) (53)
Reliable universal RT-PCR assays for studying influenza polymerase subunit gene sequences from all 16 haemagglutinin subtypes. (2007) (53)
Antibody profiles in mild and severe cases of COVID-19 (2020) (52)
Pathogenesis and transmission of SARS-CoV-2 virus in golden Syrian hamsters (2020) (52)
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection (2021) (50)
Mutagenic Analysis of the 5′ Arm of the Influenza A Virus Virion RNA Promoter Defines the Sequence Requirements for Endonuclease Activity (2001) (50)
In-Flight Transmission of SARS-CoV-2 (2020) (49)
The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception (2020) (48)
Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses (2020) (48)
IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection (2014) (47)
Surveillance of Animal Influenza for Pandemic Preparedness (2012) (47)
Comparison of the NucliSens easyMAG and Qiagen BioRobot 9604 Nucleic Acid Extraction Systems for Detection of RNA and DNA Respiratory Viruses in Nasopharyngeal Aspirate Samples (2008) (46)
Effect of moist heat reprocessing of N95 respirators on SARS-CoV-2 inactivation and respirator function (2020) (45)
Genogroup I and II Picobirnaviruses in Respiratory Tracts of Pigs (2011) (45)
Absence of MERS-Coronavirus in Bactrian Camels, Southern Mongolia, November 2014 (2015) (45)
Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients (2020) (45)
Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus. (2015) (44)
Tropism of the Novel Coronavirus SARS-CoV-2 in Human Respiratory Tract: An Analysis in Ex Vivo and In Vitro Cultures (2020) (42)
Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera (2020) (41)
Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. (2015) (41)
Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia (2017) (39)
The first case study of wastewater-based epidemiology of COVID-19 in Hong Kong (2021) (37)
Polyuridylated mRNA Synthesized by a Recombinant Influenza Virus Is Defective in Nuclear Export (2000) (36)
Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection (2021) (36)
Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020 (2020) (36)
Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias (2015) (36)
Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells. (2014) (35)
Coronavirus infections in horses in Saudi Arabia and Oman (2017) (35)
Viral genetic sequence variations in pandemic H1N1/2009 and seasonal H3N2 influenza viruses within an individual, a household and a community. (2011) (35)
Recurrent mutations associated with isolation and passage of SARS coronavirus in cells from non‐human primates (2005) (34)
In-Flight Transmission of Severe Acute Respiratory Syndrome Coronavirus 2. (2020) (33)
Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody (2014) (32)
OTUB1 is a key regulator of RIG-I dependent immune signalling and is targeted for proteasomal degradation by influenza A NS1 (2019) (30)
Generation of recombinant influenza A virus without M2 ion-channel protein by introduction of a point mutation at the 5' end of the viral intron. (2005) (29)
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection (2021) (29)
Dinucleotide evolutionary dynamics in influenza A virus (2019) (29)
SARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo (2021) (29)
Tissue Tropism of Swine Influenza Viruses and Reassortants in Ex Vivo Cultures of the Human Respiratory Tract and Conjunctiva (2011) (28)
Diversity of Dromedary Camel Coronavirus HKU23 in African Camels Revealed Multiple Recombination Events among Closely Related Betacoronaviruses of the Subgenus Embecovirus (2019) (28)
Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China (2021) (28)
Rapid Detection of Reassortment of Pandemic H1N1/2009 Influenza Virus (2010) (28)
Detection of Novel Reassortant Influenza A (H3N2) and H1N1 2009 Pandemic Viruses in Swine in Hanoi, Vietnam (2015) (28)
Comparison of virus concentration methods and RNA extraction methods for SARS-CoV-2 wastewater surveillance (2022) (27)
The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine (2018) (26)
Transgenic plant‐derived siRNAs can suppress propagation of influenza virus in mammalian cells (2004) (26)
Transmission of H7N9 Influenza Viruses with a Polymorphism at PB2 Residue 627 in Chickens and Ferrets (2015) (25)
On-Demand Droplet Collection for Capturing Single Cells. (2020) (24)
Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters (2021) (24)
The evolving threat of influenza viruses of animal origin and the challenges in developing appropriate diagnostics. (2012) (24)
Protection by universal influenza vaccine is mediated by memory CD4 T cells. (2018) (22)
SARS-CoV-2 virus transfers to skin through contact with contaminated solids (2021) (22)
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses. (2010) (22)
Lack of serological evidence of Middle East respiratory syndrome coronavirus infection in virus exposed camel abattoir workers in Nigeria, 2016 (2018) (22)
Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines (2022) (22)
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. (2020) (22)
Quantitative analysis of four rapid antigen assays for detection of pandemic H1N1 2009 compared with seasonal H1N1 and H3N2 influenza A viruses on nasopharyngeal aspirates from patients with influenza. (2012) (21)
Crouching Tiger, Hidden Dragon: The Laboratory Diagnosis of Severe Acute Respiratory Syndrome (2004) (21)
Reassortants of H5N1 Influenza Viruses Recently Isolated from Aquatic Poultry in Hong Kong SAR (2003) (21)
The ins and outs of fetal DNA in maternal plasma (2003) (21)
Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong (2018) (21)
Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection (2018) (21)
Detection of highly pathogenic influenza and pandemic influenza virus in formalin fixed tissues by immunohistochemical methods. (2012) (21)
Continuing evolution of H9N2 influenza viruses endemic in poultry in southern China. (2011) (20)
Molecular detection of human H7N9 influenza A virus causing outbreaks in China. (2013) (20)
SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021 (2021) (20)
Circulating fetal DNA in maternal plasma. (2001) (20)
Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong (2022) (20)
SARS coronavirus 8b reduces viral replication by down-regulating E via an ubiquitin-independent proteasome pathway (2010) (20)
Phenotypic and genetic characterization of MERS coronaviruses from Africa to understand their zoonotic potential (2021) (20)
Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract (2022) (19)
An early warning system for emerging SARS-CoV-2 variants (2022) (19)
Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome (2003) (19)
Influenza A viruses with different amino acid residues at PB2-627 display distinct replication properties in vitro and in vivo: revealing the sequence plasticity of PB2-627 position. (2014) (19)
Transmission of SARS-CoV-2 (Variant Delta) from Pet Hamsters to Humans and Onward Human Propagation of the Adapted Strain: A Case Study (2022) (18)
The role of influenza virus gene constellation and viral morphology on cytokine induction, pathogenesis, and viral virulence. (2009) (18)
Use of sewage surveillance for COVID-19 to guide public health response: A case study in Hong Kong (2022) (18)
SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022 (2022) (18)
Reduction of Infectivity of SARS-CoV-2 by Zinc Oxide Coatings. (2021) (18)
SARS-CoV-2 virus culture from the upper respiratory tract: Correlation with viral load, subgenomic viral RNA and duration of illness. (2020) (18)
One step closer to universal influenza epitopes (2009) (17)
Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods (2004) (17)
Transparent and Sprayable Surface Coatings that Kill Drug-Resistant Bacteria Within Minutes and Inactivate SARS-CoV-2 Virus (2021) (16)
Heterologous influenza vRNA segments with identical non-coding sequences stimulate viral RNA replication in trans (2008) (16)
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children (2021) (16)
Omicron BA.1 and BA.2 sub-lineages show reduced pathogenicity and transmission potential than the early SARS-CoV-2 D614G variant in Syrian hamsters (2022) (14)
Swine Influenza in Sri Lanka (2013) (14)
Science, not speculation, is essential to determine how SARS-CoV-2 reached humans (2021) (13)
Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults (2020) (12)
Transparent Anti-SARS-CoV-2 and Antibacterial Silver Oxide Coatings (2022) (12)
Air travel-related outbreak of multiple SARS-CoV-2 variants (2021) (12)
SARS-CoV-2 accessory proteins reveal distinct serological signatures in children (2022) (12)
The Phylodynamics of Seasonal Influenza A/H1N1pdm Virus in China Between 2009 and 2019 (2020) (11)
A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4 (2022) (11)
SARS-CoV-2 under an elimination strategy in Hong Kong (2021) (11)
The Emergence of Human Coronavirus EMC: How Scared Should We Be? (2013) (10)
Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022 (2022) (10)
Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening (2018) (10)
Detection of SARS Coronavirus (2010) (10)
Rapid Genotyping of Swine Influenza Viruses (2011) (10)
Severe Acute Respiratory Syndrome (SARS) (2008) (10)
Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2 (2020) (10)
Efficient Detection of BRAF Mutation in Plasma of Patients after Long- term Storage of Blood in Cell-Free DNA Blood Collection Tubes (2015) (10)
Characterization of influenza A viruses with polymorphism in PB2 residues 701 and 702 (2017) (9)
A six‐plex droplet digital RT‐PCR assay for seasonal influenza virus typing, subtyping, and lineage determination (2020) (9)
Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain (2022) (9)
Transmissibility of pandemic H1N1 and genetically related swine influenza viruses in ferrets (2011) (8)
Surveillance of Rodent Pests for SARS-CoV-2 and Other Coronaviruses, Hong Kong (2022) (8)
Real-time allelic assays of SARS-CoV-2 variants to enhance sewage surveillance (2022) (8)
Detection of SARS Coronavirus in Humans and Animals by Conventional and Quantitative (Real Time) Reverse Transcription Polymerase Chain Reactions (2007) (8)
Thermal Disinfection Inactivates SARS-CoV-2 in N95 Respirators while Maintaining Their Protective Function (2020) (8)
Phylogenetic Analysis of MERS-CoV in a Camel Abattoir, Saudi Arabia, 2016–2018 (2020) (8)
Risk assessment of the tropism & pathogenesis of the highly pathogenic avian influenza A/H7N9 virus using ex vivo & in vitro cultures of human respiratory tract. (2019) (8)
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection (2022) (8)
Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells (2020) (7)
Use of Sewage Surveillance for COVID-19: A Large-Scale Evidence-Based Program in Hong Kong (2022) (7)
Erratum: Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (International Journal of Laboratory Medicine and Molecular Diagnostics (2003) 49 (953-5) (2003) (7)
New England Medical Journal (2007) (7)
Quantification of SARS-CoV-2 RNA in wastewater treatment plants mirrors the pandemic trend in Hong Kong (2022) (7)
Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection (2020) (7)
Circulation of Influenza A(H5N8) Virus, Saudi Arabia (2018) (7)
Influenza A Virus Infections in Dromedary Camels, Nigeria and Ethiopia, 2015–2017 (2020) (7)
Multivariate Analyses of Codon Usage in 2019 Novel Coronavirus on the Genomic Landscape of Betacoronavirus (2020) (6)
Molecular Epidemiology of Influenza A(H1N1)pdm09 Virus among Humans and Swine, Sri Lanka (2014) (6)
Evaluation of novel H1N1-specific primer-probe sets using commercial RT-PCR mixtures and a premixed reaction stored in a lyophilized format. (2010) (6)
Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine (2022) (6)
Preexisting Antibody-Dependent Cellular Cytotoxicity-Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure. (2016) (6)
Cross‐reactive antibody‐dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmission (2019) (6)
Anti-pathogen stainless steel combating COVID-19 (2021) (6)
Identification of influenza polymerase inhibitors targeting polymerase PB2 cap‐binding domain through virtual screening (2017) (5)
Occult respiratory viral infections in coronial autopsies: a pilot project. (2009) (5)
Evaluation of RT-qPCR Primer-Probe Sets to Inform Public Health Interventions Based on COVID-19 Sewage Tests (2022) (5)
Evidence-Based Options for Controlling Respiratory Virus Transmission (2017) (5)
Detection of Group 1 Coronaviruses in Bats Using Universal Coronavirus Reverse Transcription Polymerase Chain Reactions (2007) (5)
Pseudoparticle Neutralization Assay for Detecting Ebola- Neutralizing Antibodies in Biosafety Level 2 Settings (2015) (5)
Title Proinflammatory cytokine responses induced by influenza A ( H 5 N 1 ) viruses in primary human alveolar and bronchial epithelial cells (2005) (5)
SARS-CoV-2 Omicron variant is more stable than the ancestral strain on various surfaces (2022) (5)
Genetic Diversity of SARS-CoV-2 among Travelers Arriving in Hong Kong (2021) (5)
A novel molecular test for influenza B virus detection and lineage differentiation (2014) (5)
Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection. (2018) (4)
Vaccination with ADCC activating HA peptide epitopes provides 1 partial protection from influenza infection (2020) (4)
Age-specific genetic and antigenic variations of influenza A viruses in Hong Kong, 2013–2014 (2016) (4)
Strength and durability of antibody responses to BNT162b2 and CoronaVac (2022) (4)
Retinoic acid induces down-regulation of Wnt-3a, apoptosis and diversion of tail bud cells to a neural fate in the mouse embryo (vol 84, pg 17, 1999) (1999) (4)
Risk of within-hotel transmission of SARS-CoV-2 during on-arrival quarantine in Hong Kong: an epidemiological and phylogenomic investigation (2023) (3)
Reprocessing N95 Respirators During the COVID-19 Pandemic: Moist Heat Inactivates SARS-CoV-2 and Maintains N95 Filtration (2020) (3)
A novel mechanism of enhanced transcription activity and fidelity for influenza A viral RNA-dependent RNA polymerase (2021) (3)
Sars and Other Coronaviruses in Humans and Animals (2006) (3)
Reply to ‘Reconciling disparate estimates of viral genetic diversity during human influenza infections’ (2019) (3)
Natural Reassortment of Eurasian Avian-Like Swine H1N1 and Avian H9N2 Influenza Viruses in Pigs, China (2022) (3)
Monitoring International Travelers Arriving in Hong Kong for Genomic Surveillance of SARS-CoV-2 (2022) (3)
Novel Zoonotic Avian Influenza A(H3N8) Virus in Chicken, Hong Kong, China (2022) (3)
Effect of Surface Porosity on SARS-CoV-2 Fomite Infectivity (2022) (3)
Recombinant influenza virus with a pandemic H2N2 polymerase complex has a higher adaptive potential than one with seasonal H2N2 polymerase complex. (2016) (3)
Homologous and heterologous boosting with CoronaVac and BNT162b2: a randomized trial (the Cobovax study) (2022) (3)
Multiplex Screening Assay for Identifying Cytotoxic CD8+ T Cell Epitopes (2020) (3)
Novel coronaviruses and astroviruses in bats (2009) (3)
The SARS coronavirus (SARS-CoV) (2006) (3)
A Push for Real Normal: Mass Screening for COVID-19 (2021) (2)
A46 MERS-CoV in Arabian camels in Africa and Central Asia (2017) (2)
A statistical strategy to identify recombinant viral ribonucleoprotein of avian, human, and swine influenza A viruses with elevated polymerase activity (2013) (2)
Exploring the landscape of immune responses to influenza infection and vaccination (2022) (2)
Next-generation T cell–activating vaccination increases influenza virus mutation prevalence (2022) (2)
This information is current as IFN Regulatory Factor 3 and p38 MAPK A Virus (H5N1) Is Selectively Regulated by Primary Human Macrophages by Influenza Induction of Proinflammatory Cytokines in (2014) (2)
Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) (Coronaviridae) (2020) (2)
Characterization of a novel coronavirus responsible for severe acute respiratory syndrome (2004) (2)
Use of fractional factorial design to study the compatibility of viral ribonucleoprotein gene segments of human H7N9 virus and circulating human influenza subtypes (2014) (2)
Neutralizing antibody titres in SARS-CoV-2 infections (2021) (2)
Within-host diversity of SARS-CoV-2 lineages and effect of vaccination (2022) (2)
Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong (2023) (2)
Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study (2023) (2)
Image-based single-cell biophysical phenotyping of SARS-CoV-2 infection by high-throughput quantitative phase imaging flow cytometry (2022) (1)
BNT162b2 vaccine boosts neutralizing antibodies to ancestral SARS-CoV-2 & Omicron variant in adults who previously received two doses of inactivated vaccine (2022) (1)
Identification of a novel interaction between the M2 proton channel of influenza A virus and cyclin D3: consequences for cell cycle progression (2011) (1)
Vaccine-induced T cell protection from influenza viruses. (2019) (1)
Droplet‐Based Microfluidics: On‐Demand Droplet Collection for Capturing Single Cells (Small 9/2020) (2020) (1)
Circulating fetal RNA in maternal plasma: the next stage in noninvasive prenatal diagnosis. (2002) (1)
Universal influenza vaccines are futile when benchmarked against seasonal influenza vaccines. (2022) (1)
Corrigendum to “Transgenic plant‐derived siRNAs can suppress propagation of influenza virus in mammalian cells” [FEBS Lett. 577 (2004) 345–350] (2006) (1)
Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals (2023) (1)
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses (2022) (1)
Transcription of influenza A virus genes (2001) (1)
Viral Diagnosis of SARS (2008) (1)
Evolution of H5N1 influenza viruses in Asia. (2005) (1)
Surveillance of influenza viruses in swine in Hong Kong abattoir: methods and feasibility (2011) (1)
Title Human monoclonal antibody combination against SARScoronavirus : Synergy and coverage of escape mutants (2006) (1)
Effect of Anticoagulants and Storage Temperature on the Stability of Receptor Activator for Nuclear Factor- (cid:3) B Ligand and Osteoprotegerin in Plasma and Serum, (2003) (1)
Rapid Detection of the Severe Acute Respiratory Syn- drome (SARS) Coronavirus by a Loop-Mediated Iso- (2004) (1)
A rapid, high-throughput, and sensitive PEG-precipitation method for SARS-CoV-2 wastewater surveillance (2022) (1)
Genetic diversity and molecular epidemiology of Middle East Respiratory Syndrome Coronavirus in dromedaries in Ethiopia, 2017–2020 (2023) (1)
The episodic resurgence of highly pathogenic avian influenza H5 virus (2022) (1)
Emerging Nidovirus Infections (2008) (1)
Definition of the cellular interactome of the highly pathogenic avian influenza H5N1 virus: identification of human cellular regulators of viral entry, assembly, and egress. (2016) (1)
Network analysis of swine value chain: towards efficient zoonotic disease surveillance programs in Vietnam. [094] (2016) (0)
A Pregnant Woman with Influenza A Encephalopathy in Whom Influenza A/Hong Kong Virus (H3) Was Isolated from Cerebrospinal Fluid: Case Report (2008) (0)
One step closer to a universal influenza A vaccine? (2011) (0)
Title Comparison of serological assays in human Middle Eastrespiratory syndrome ( MERS )-coronavirus infection (2015) (0)
Title Influenza a virus expresses high levels of an unusual class ofsmall viral leader RNAs in infected cells (2010) (0)
Influenza Polymerase Subunits Compatibility between H1 and H5 viruses (2008) (0)
Patent Application Title: Provisional USA Patent: Identification of novel small-molecule inhibitors of the avian influenza H5N1 virus determined through computational screening. (2009) (0)
Identification of human annexin A6 as a novel cellular interactant of influenza A M2 protein: implications for influenza life cycle (2011) (0)
Detection of SARS coronavirus in animals and in humans (2004) (0)
Evaluation of Reverse Transcriptase-Strand Displacement Amplification (BD ProbetecTM) for Rapid Diagnosis of SARS Coronavirus Infection (2005) (0)
Localized antibody responses in influenza virus-infected mice (2013) (0)
Prenatal detection of fetal Down's syndrome (2001) (0)
As a vaccine suitable attenuated influenza virus (2000) (0)
MERS coronavirus in camels (2014) (0)
Use of reverse transcription loop-mediated isothermal amplification for molecular detection of highly pathogenic H5N1 influenza A viruses (2007) (0)
Coronavirus in wildlife (2011) (0)
Erratum: Prenatal detection of fetal Down's syndrome (Lancet (599)) (2001) (0)
The Severe Acute Respiratory Syndrome (SARS) Coronavirus NTPase/Helicase Belongs to a Distinct Class of 5 to 3 Viral Helicases*□S (2003) (0)
Mice IL-15 Confer Sterile Cross-Clade Protection Avian Influenza Vaccines Adjuvanted with Vaccinia Virus-Based Multivalent H 5 N 1 Perera (2009) (0)
Influenza viruses in healthy wild birds in Hong Kong (2007) (0)
Stalling of RNAPIIo by DNA intercalators activates influenza transcription and virus replication (2011) (0)
Sequence plasticity of PB2-627 position of influenza A virus demonstrates distinct replication properties in vitro and in vivo (2015) (0)
Flu, a striking example of emerging disease (2011) (0)
Inhibition of influenza viral replication using siRNA delivered by pH-responsive peptides (2013) (0)
SARS: Etiology, diagnostics, transmission and clinical aspects. (2004) (0)
Characterization of influenza A viruses with different amino acid residues at PB2-627 (2013) (0)
The Holy Grail: Universal Vaccines for Influenza? (2011) (0)
DNA intercalator stimulates influenza transcription and virus replication (2011) (0)
Universal influenza vaccine utilizes T cells for mechanism of protection as killers and coordinators (2015) (0)
The Cause of Severe Acute Respiratory Syndrome: What Did We Learn from It? (2020) (0)
Title Characterization of influenza A viruses with polymorphism inPB 2 residues 701 and 702 (2017) (0)
Title Circulation of Influenza A ( H 5 N 8 ) Virus , Saudi Arabia (2018) (0)
Detection of Human Inﬂuenza A Viruses by Loop-Mediated Isothermal Ampliﬁcation (2004) (0)
nnn The SARS-CoV-2 outbreak: diagnosis, infection prevention, and public perception (2020) (0)
Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening (2018) (0)
Modulates Infection A Virus Protein M 2 and Negatively Human Annexin A 6 Interacts with Influenza (2012) (0)
Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccine (2022) (0)
Emergence of a novel human coronavirus threatening human health (2020) (0)
Ultrafast disinfection of SARS-CoV-2 viruses (2022) (0)
Infection of dogs with SARS-CoV-2 (2020) (0)
Title Age-specific genetic and antigenic variations of influenza Aviruses in Hong Kong , 2013 – 2014 (2016) (0)
Influenza Virus in Mammalian Hosts Pathogenicity of the Novel A / H 7 N 9 Basic Protein 2 Gene Contribute to the Amino Acid Substitutions in Polymerase (2014) (0)
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo (2022) (0)
Community-Acquired Staphylococcus argenteus Sequence Type 2250 Bone and Joint Infection, France, 2017 (2019) (0)
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection (2020) (0)
101 The role of interferon regulatory factor 3 and p38 in influenza a virus induced pro-inflammatory cytokines (2008) (0)
Tropism of the Novel Coronavirus SARS-CoV-2 in Human Respiratory Tract: An Analysis in In Vitro Cultures (2020) (0)
Replication of Novel Zoonotic-Like Influenza A(H3N8) Virus in Ex Vivo Human Bronchus and Lung. (2023) (0)
Development of multiplex RT‐ddPCR assays for detection of SARS‐CoV‐2 and other common respiratory virus infections (2022) (0)
Characterization of influenza A viruses with polymorphism in PB2 residues 701 and 702 (2017) (0)
Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2 (2020) (0)
Short Communication Coronaviruses in bent-winged bats (Miniopterus spp.) (2006) (0)
Influenza A (H5N1/97) viruses are potent inducers of pro-inflrammatory cytokines (2002) (0)
For a better, safer and healthier tomorrow - Our commitment to research in emerging infectious diseases at the University of Hong Kong (2004) (0)
Early vaccine mediated strain specific cytokine imbalance induces mild immunopathology during influenza infection. (2022) (0)
Title DNA intercalator stimulates influenza transcription and virusreplication (2011) (0)
Identification and characterization of a coronavirus causing severe acute respiratory syndrome. (2003) (0)
Title Stalking influenza by vaccination with pre-fusion headless HAmini-stem (2016) (0)
Title Detection of novel astroviruses in urban brown rats andpreviously known astroviruses in humans (2010) (0)
Mini viral RNAs act as innate immune agonists during influenza virus infection (2018) (0)
Nsp9 protein from SARS-coronavirus. (2004) (0)
Amphipathic peptides-mediated delivery of siRNA for antiviral therapy against influenza (2013) (0)
SARS etiology, transmission and diagnostic (2004) (0)
Commentary-Fetal RNA in maternal plasma: the next stage in noninvasive prenatal diagnosis (2002) (0)
Virus attenue de la grippe utilisable comme vaccin (2000) (0)
Heterosubtypic immune pressure accelerates emergence of influenza A virus escape phenotypes in mice. (2022) (0)
MINIREVIEW Influenza: Emergence and Control (2004) (0)
Mutation nsp6 L232F associated with MERS-CoV zoonotic transmission confers higher viral replication in human respiratory tract cultures ex-vivo (2023) (0)
Generation and characterization of influenza A viruses with altered mutational frequencies (2014) (0)
Formulation of siRNA with pH-responsive amphipathic peptides for inhalation against respiratory infectious diseases (2013) (0)
Universal influenza vaccinia vaccine requires CD4+ T cells for heterosubtypic protection (2013) (0)
Title Heterosubtypic neutralizing monoclonal antibodies cross-protective against H 5 N 1 and H 1 N 1 recovered from human IgM + memory B cells (2008) (0)
Influenza Polymerase Subunits Compatibility Between Human H1 and H5 Viruses (2008) (0)
Animal/Avian influenza and pandemic disease (2004) (0)
SARS and other “new” coronaviruses. (2007) (0)
The protective role of homozygous L-SIGN (CLEC4M) in SARS coronavirus infection. (2006) (0)
Identification of a Novel small-molecule inhibitor of avian influenza H5N1 virus through computational screening against neuraminidase (2009) (0)

This paper list is powered by the following services:

Other Resources About Leo Poon

en.wikipedia.org

What Schools Are Affiliated With Leo Poon?

Leo Poon is affiliated with the following schools: